U
QSAM Biosciences, Inc. A408WA
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -62.16% -17.99% -25.45% -43.28% -73.24%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -60.46% -4.60% -2.01% -39.78% -66.38%
Operating Income 60.46% 4.60% 2.01% 39.78% 66.38%
Income Before Tax 58.85% 5.63% 3.55% 15.73% 67.45%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 58.85% 5.63% 3.55% 15.73% 67.45%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 58.85% 5.63% 3.55% 15.73% 67.45%
EBIT 60.46% 4.60% 2.01% 39.78% 66.38%
EBITDA -- -- -- -- --
EPS Basic -- -- -- -- --
Normalized Basic EPS -- -- -- -- --
EPS Diluted -- -- -- -- --
Normalized Diluted EPS -- -- -- -- --
Average Basic Shares Outstanding -- -- -- -- --
Average Diluted Shares Outstanding -- -- -- -- --
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings